BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 26823495)

  • 1. GSK-3β Governs Inflammation-Induced NFATc2 Signaling Hubs to Promote Pancreatic Cancer Progression.
    Baumgart S; Chen NM; Zhang JS; Billadeau DD; Gaisina IN; Kozikowski AP; Singh SK; Fink D; Ströbel P; Klindt C; Zhang L; Bamlet WR; Koenig A; Hessmann E; Gress TM; Ellenrieder V; Neesse A
    Mol Cancer Ther; 2016 Mar; 15(3):491-502. PubMed ID: 26823495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of a nuclear NFATc2 protein stabilization loop confers breast and pancreatic cancer growth suppression by zoledronic acid.
    Singh SK; Baumgart S; Singh G; König AO; Reutlinger K; Hofbauer LC; Barth P; Gress TM; Lomberk G; Urrutia R; Fernandez-Zapico ME; Ellenrieder V
    J Biol Chem; 2011 Aug; 286(33):28761-28771. PubMed ID: 21628454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restricted heterochromatin formation links NFATc2 repressor activity with growth promotion in pancreatic cancer.
    Baumgart S; Glesel E; Singh G; Chen NM; Reutlinger K; Zhang J; Billadeau DD; Fernandez-Zapico ME; Gress TM; Singh SK; Ellenrieder V
    Gastroenterology; 2012 Feb; 142(2):388-98.e1-7. PubMed ID: 22079596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycogen synthase kinase-3β ablation limits pancreatitis-induced acinar-to-ductal metaplasia.
    Ding L; Liou GY; Schmitt DM; Storz P; Zhang JS; Billadeau DD
    J Pathol; 2017 Sep; 243(1):65-77. PubMed ID: 28639695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between NFATc2 and the transcription factor Sp1 in pancreatic carcinoma cells PaTu 8988t.
    Malsy M; Graf B; Almstedt K
    BMC Mol Biol; 2017 Aug; 18(1):20. PubMed ID: 28774282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The active role of the transcription factor Sp1 in NFATc2-mediated gene regulation in pancreatic cancer.
    Malsy M; Graf B; Almstedt K
    BMC Biochem; 2019 Jan; 20(1):2. PubMed ID: 30696421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant nuclear accumulation of glycogen synthase kinase-3beta in human pancreatic cancer: association with kinase activity and tumor dedifferentiation.
    Ougolkov AV; Fernandez-Zapico ME; Bilim VN; Smyrk TC; Chari ST; Billadeau DD
    Clin Cancer Res; 2006 Sep; 12(17):5074-81. PubMed ID: 16951223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NFATc1 Links EGFR Signaling to Induction of Sox9 Transcription and Acinar-Ductal Transdifferentiation in the Pancreas.
    Chen NM; Singh G; Koenig A; Liou GY; Storz P; Zhang JS; Regul L; Nagarajan S; Kühnemuth B; Johnsen SA; Hebrok M; Siveke J; Billadeau DD; Ellenrieder V; Hessmann E
    Gastroenterology; 2015 May; 148(5):1024-1034.e9. PubMed ID: 25623042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutant K-Ras increases GSK-3β gene expression via an ETS-p300 transcriptional complex in pancreatic cancer.
    Zhang JS; Koenig A; Harrison A; Ugolkov AV; Fernandez-Zapico ME; Couch FJ; Billadeau DD
    Oncogene; 2011 Aug; 30(34):3705-15. PubMed ID: 21441955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation-induced NFATc1-STAT3 transcription complex promotes pancreatic cancer initiation by KrasG12D.
    Baumgart S; Chen NM; Siveke JT; König A; Zhang JS; Singh SK; Wolf E; Bartkuhn M; Esposito I; Heßmann E; Reinecke J; Nikorowitsch J; Brunner M; Singh G; Fernandez-Zapico ME; Smyrk T; Bamlet WR; Eilers M; Neesse A; Gress TM; Billadeau DD; Tuveson D; Urrutia R; Ellenrieder V
    Cancer Discov; 2014 Jun; 4(6):688-701. PubMed ID: 24694735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycogen synthase kinase-3β: a novel therapeutic target for pancreatic cancer.
    Ding L; Billadeau DD
    Expert Opin Ther Targets; 2020 May; 24(5):417-426. PubMed ID: 32178549
    [No Abstract]   [Full Text] [Related]  

  • 12. Oncogenic K-ras stimulates Wnt signaling in colon cancer through inhibition of GSK-3beta.
    Li J; Mizukami Y; Zhang X; Jo WS; Chung DC
    Gastroenterology; 2005 Jun; 128(7):1907-18. PubMed ID: 15940626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycogen Synthase Kinase 3β: A True Foe in Pancreatic Cancer.
    Elmadbouh OHM; Pandol SJ; Edderkaoui M
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GSK-3 directly regulates phospho-4EBP1 in renal cell carcinoma cell-line: an intrinsic subcellular mechanism for resistance to mTORC1 inhibition.
    Ito H; Ichiyanagi O; Naito S; Bilim VN; Tomita Y; Kato T; Nagaoka A; Tsuchiya N
    BMC Cancer; 2016 Jul; 16():393. PubMed ID: 27387559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of β-catenin signaling suppresses pancreatic tumor growth by disrupting nuclear β-catenin/TCF-1 complex: critical role of STAT-3.
    Pramanik KC; Fofaria NM; Gupta P; Ranjan A; Kim SH; Srivastava SK
    Oncotarget; 2015 May; 6(13):11561-74. PubMed ID: 25869100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycogen synthase kinase-3beta participates in nuclear factor kappaB-mediated gene transcription and cell survival in pancreatic cancer cells.
    Ougolkov AV; Fernandez-Zapico ME; Savoy DN; Urrutia RA; Billadeau DD
    Cancer Res; 2005 Mar; 65(6):2076-81. PubMed ID: 15781615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nerve growth factor prevents arsenic-induced toxicity in PC12 cells through the AKT/GSK-3β/NFAT pathway.
    Tan Z; Kang T; Zhang X; Tong Y; Chen S
    J Cell Physiol; 2019 Apr; 234(4):4726-4738. PubMed ID: 30256405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WNT5A-NFAT signaling mediates resistance to apoptosis in pancreatic cancer.
    Griesmann H; Ripka S; Pralle M; Ellenrieder V; Baumgart S; Buchholz M; Pilarsky C; Aust D; Gress TM; Michl P
    Neoplasia; 2013 Jan; 15(1):11-22. PubMed ID: 23359789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signal transducers and activators of transcription 3-induced metastatic potential in gastric cancer cells is enhanced by glycogen synthase kinase-3β.
    Yoon J; Ko YS; Cho SJ; Park J; Choi YS; Choi Y; Pyo JS; Ye SK; Youn HD; Lee JS; Chang MS; Kim MA; Lee BL
    APMIS; 2015 May; 123(5):373-82. PubMed ID: 25846563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulation of glycogen synthase kinase-3beta signaling in hepatocellular carcinoma cells.
    Desbois-Mouthon C; Blivet-Van Eggelpoël MJ; Beurel E; Boissan M; Delélo R; Cadoret A; Capeau J
    Hepatology; 2002 Dec; 36(6):1528-36. PubMed ID: 12447879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.